搜尋





搜尋





市場行情
/
股票
/
imvt
/

Immunovant Inc

IMVT

添加自選

38.620USD

-0.860-2.18%

收盤 07-31 16:00（美東）報價延遲15分鐘

7.88B總市值

虧損本益比TTM

Immunovant Inc

38.620

-0.860-2.18%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

IMVT 利潤表

您可以在這裡找到Immunovant Inc的年度或季度收入報告，以深入了解Immunovant Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q4

FY2026Q3

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

營業費用

5.95%120.60M

0.05%114.36M

13.84%131.76M

34.94%127.22M

40.73%113.83M

85.70%114.30M

87.29%115.74M

42.90%94.28M

25.86%80.88M

13.93%61.55M

24.56%61.80M

63.41%65.98M

36.06%64.26M

30.91%54.03M

31.78%49.61M

35.10%40.38M

63.32%47.23M

30.44%41.27M

79.51%37.65M

12.41%29.89M

41.18%28.92M

7437.69%31.64M

22613.39%20.97M

5907900.00%26.59M

--20.48M

--419.76K

--92.34K

--450.00

研發費用

10.34%103.33M

4.66%98.92M

17.45%114.25M

34.09%101.20M

41.78%93.65M

95.54%94.52M

102.82%97.27M

49.23%75.47M

27.43%66.06M

14.40%48.34M

27.08%47.96M

77.90%50.58M

62.06%51.84M

41.99%42.25M

76.67%37.74M

51.99%28.43M

71.83%31.99M

41.08%29.76M

78.37%21.36M

10.54%18.70M

31.39%18.61M

325.82%21.09M

--11.98M

--16.92M

--14.17M

--4.95M

----

折舊攤銷及損耗

-11.93%96.00K

2.02%101.00K

17.98%105.00K

33.75%107.00K

70.31%109.00K

70.69%99.00K

58.93%89.00K

50.94%80.00K

18.52%64.00K

18.37%58.00K

21.74%56.00K

20.45%53.00K

38.46%54.00K

48.48%49.00K

64.29%46.00K

69.23%44.00K

77.27%39.00K

73.68%33.00K

100.00%28.00K

160.00%26.00K

266.67%22.00K

26.67%19.00K

--14.00K

--10.00K

--6.00K

--15.00K

----

其他營業費用

----

--395.16K

--67.74K

--450.00

營業利潤

-5.95%-120.60M

-0.05%-114.36M

-13.84%-131.76M

-34.94%-127.22M

-40.73%-113.83M

-85.70%-114.30M

-87.29%-115.74M

-42.90%-94.28M

-25.86%-80.88M

-13.93%-61.55M

-24.56%-61.80M

-63.41%-65.98M

-36.06%-64.26M

-30.91%-54.03M

-31.78%-49.61M

-35.10%-40.38M

-63.32%-47.23M

-30.44%-41.27M

-79.51%-37.65M

-12.41%-29.89M

-41.18%-28.92M

-7437.69%-31.64M

-22613.39%-20.97M

-5907900.00%-26.59M

---20.48M

---419.76K

---92.34K

---450.00

淨非營業利息收入（費用）

利息收入

16.96%8.06M

16.19%5.33M

-7.72%5.60M

-11.74%6.34M

-17.79%6.89M

-48.62%4.59M

70.02%6.07M

76.63%7.18M

140.78%8.38M

203.43%8.93M

209.53%3.57M

--4.07M

--3.48M

--2.94M

--1.15M

----

--683.14K

--341.56K

----

利息費用

----

--0.00

-100.00%0.00

--0.00

----

--0.00

--376.00K

----

特殊收入（費用）

---38.95M

----

--0.00

100.00%0.00

--0.00

100.00%0.00

--0.00

---12.50M

--0.00

---10.00M

----

其他非經營性收入（費用）

-25.49%798.00K

95.71%-54.00K

-60.25%250.00K

4139.29%1.19M

141.40%1.07M

-214.99%-1.26M

3045.00%629.00K

-93.97%28.00K

-826.69%-2.59M

162.27%1.09M

-97.48%20.00K

31.07%464.00K

709.09%356.00K

-1441.23%-1.76M

1044.05%793.00K

156.55%354.00K

-93.53%44.00K

77.34%-114.00K

-137.33%-84.00K

-745.95%-626.00K

635.43%680.00K

-327.60%-503.00K

--225.00K

---74.00K

---127.00K

--221.00K

----

稅前利潤

-42.35%-150.70M

1.70%-109.08M

-15.47%-125.91M

-37.47%-119.70M

-40.99%-105.87M

-115.37%-110.97M

-87.33%-109.04M

-17.75%-87.07M

-24.27%-75.09M

18.00%-51.53M

-22.11%-58.21M

-84.77%-73.95M

-28.06%-60.42M

-51.84%-62.84M

-26.32%-47.67M

-31.16%-40.02M

-67.10%-47.18M

-28.75%-41.38M

-81.86%-37.73M

-14.45%-30.51M

-37.01%-28.24M

-12303.90%-32.14M

-8425.71%-20.75M

-5924344.44%-26.66M

---20.61M

--263.38K

--249.22K

---450.00

所得稅

-587.82%-2.84M

921.05%1.55M

661.54%594.00K

1085.71%913.00K

151.29%583.00K

240.74%152.00K

-82.82%78.00K

800.00%77.00K

123.41%232.00K

-127.91%-108.00K

73.95%454.00K

-103.13%-11.00K

-8158.33%-991.00K

--387.00K

941.94%261.00K

958.54%352.00K

84.81%-12.00K

100.00%0.00

-177.50%-31.00K

-185.42%-41.00K

-33.90%-79.00K

-365.38%-367.00K

-39.82%40.00K

--48.00K

---59.00K

--138.29K

--66.47K

----

除稅後利潤

-38.90%-147.86M

0.44%-110.64M

-15.93%-126.50M

-38.40%-120.61M

-41.33%-106.45M

-116.11%-111.12M

-86.01%-109.12M

-17.87%-87.15M

-26.73%-75.32M

18.68%-51.42M

-22.40%-58.66M

-83.13%-73.94M

-25.99%-59.43M

-52.78%-63.23M

-27.12%-47.93M

-32.50%-40.37M

-67.52%-47.17M

-30.24%-41.38M

-81.36%-37.70M

-14.09%-30.47M

-37.02%-28.16M

-25502.51%-31.78M

-11475.71%-20.79M

-5935011.11%-26.71M

---20.55M

--125.09K

--182.75K

---450.00

持續經營利潤

-38.90%-147.86M

0.44%-110.64M

-15.93%-126.50M

-38.40%-120.61M

-41.33%-106.45M

-116.11%-111.12M

-86.01%-109.12M

-17.87%-87.15M

-26.73%-75.32M

18.68%-51.42M

-22.40%-58.66M

-83.13%-73.94M

-25.99%-59.43M

-52.78%-63.23M

-27.12%-47.93M

-32.50%-40.37M

-67.52%-47.17M

-30.24%-41.38M

-81.36%-37.70M

-14.09%-30.47M

-37.02%-28.16M

-25502.51%-31.78M

-11475.71%-20.79M

-5935011.11%-26.71M

---20.55M

--125.09K

--182.75K

---450.00

歸属于母公司的淨利潤

-38.90%-147.86M

0.44%-110.64M

-15.93%-126.50M

-38.40%-120.61M

-41.33%-106.45M

-116.11%-111.12M

-86.01%-109.12M

-17.87%-87.15M

-26.73%-75.32M

18.68%-51.42M

-22.40%-58.66M

-83.13%-73.94M

-25.99%-59.43M

-52.78%-63.23M

-27.12%-47.93M

-32.50%-40.37M

-67.52%-47.17M

-30.24%-41.38M

-81.36%-37.70M

-14.09%-30.47M

-37.02%-28.16M

-25502.51%-31.78M

-11475.71%-20.79M

-5935011.11%-26.71M

---20.55M

--125.09K

--182.75K

---450.00

歸屬普通股東的淨利潤

-38.90%-147.86M

0.44%-110.64M

-15.93%-126.50M

-38.40%-120.61M

-41.33%-106.45M

-116.11%-111.12M

-86.01%-109.12M

-17.87%-87.15M

-26.73%-75.32M

18.68%-51.42M

-22.40%-58.66M

-83.13%-73.94M

-25.99%-59.43M

-52.78%-63.23M

-27.12%-47.93M

-32.50%-40.37M

-67.52%-47.17M

-30.24%-41.38M

-81.36%-37.70M

-14.09%-30.47M

-37.02%-28.16M

-25502.51%-31.78M

-11475.71%-20.79M

-5935011.11%-26.71M

---20.55M

--125.09K

--182.75K

---450.00

基本每股收益

-13.75%-0.73

19.41%-0.61

2.21%-0.73

-18.32%-0.71

-23.57%-0.64

-112.58%-0.76

-66.57%-0.74

-5.30%-0.60

-13.36%-0.52

27.65%-0.36

-8.79%-0.45

-63.56%-0.57

-12.52%-0.46

-36.68%-0.49

-18.95%-0.41

-11.74%-0.35

-40.76%-0.41

-10.87%-0.36

-40.25%-0.35

17.80%-0.31

23.53%-0.29

-3830.00%-0.32

-2039.02%-0.25

-942725.00%-0.38

---0.38

--0.01

--0.00

稀釋每股收益

-13.75%-0.73

19.41%-0.61

2.21%-0.73

-18.32%-0.71

-23.57%-0.64

-112.58%-0.76

-66.57%-0.74

-5.30%-0.60

-13.36%-0.52

27.65%-0.36

-8.79%-0.45

-63.56%-0.57

-12.52%-0.46

-36.68%-0.49

-18.95%-0.41

-11.74%-0.35

-40.76%-0.41

-10.87%-0.36

-40.25%-0.35

17.80%-0.31

23.53%-0.29

-3830.00%-0.32

-2039.02%-0.25

-942725.00%-0.38

---0.38

--0.01

--0.00

每股派息

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Immunovant Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 IMVT 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Immunovant Inc 全年的淨利潤是多少？



Immunovant Inc 2025 財年淨利潤為 -505.61M。

Immunovant Inc 上一季度的淨利潤是多少？



Immunovant Inc 最近一個季度的淨利潤為 -147.86M。

Immunovant Inc 年度營業利潤是多少？



Immunovant Inc 2025 財年的營業利潤為 -438.15M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。